These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 6776761)

  • 1. Glipizide: experimental study and comparison with other sulfonylureas.
    Loubatieres-Mariani MM
    Acta Endocrinol Suppl (Copenh); 1980; 239():26-32. PubMed ID: 6776761
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide).
    Loubatiéres A; Mariani MM; Ribes G; Alric R
    Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200675
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experimental study of glipizide. A comparison with other hypoglycemic sulfonamides (author's transl)].
    Loubatières AL; Loubatieres-Mariani MM; Alric R; Ribes G; Sorial G; Tarasco A
    Diabete Metab; 1975 Mar; 1():13-21. PubMed ID: 824163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of tolbutamide, glyburide and glipizide administered supraspinally on CA3 hippocampal neuronal cell death and hyperglycemia induced by kainic acid in mice.
    Kim CH; Park SH; Sim YB; Kim SS; Kim SJ; Lim SM; Jung JS; Suh HW
    Brain Res; 2014 May; 1564():33-40. PubMed ID: 24713348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glipizide and hepatic glycogenolysis.
    Bloch K; Daturi S; Tommasini R
    Acta Endocrinol Suppl (Copenh); 1980; 239():11-4. PubMed ID: 7001838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A controlled study of the hypoglycemic and insulinopoietic effect of glipizide and glibenclamide in non-diabetic human subjects.
    Ceretti AP; Losi S; Orsini G; Emanueli A
    Arzneimittelforschung; 1975 Apr; 25(4):675-6. PubMed ID: 808231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ["First" and "second" generation sulfonylureas: distinction or difference? (author's transl)].
    Balant L
    Diabete Metab; 1978 Jun; 4(2):135-43. PubMed ID: 98364
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of glipizide on the insulin production by isolated mouse pancreatic islets.
    Andersson A; Borg LA
    Acta Endocrinol Suppl (Copenh); 1980; 239():37-41. PubMed ID: 7001842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacological aspects of comparative studies on different blood sugar-lowering sulfonylureas].
    Beyer J; Haupt E; Cordes U; Sell G; Schöffling K
    Arzneimittelforschung; 1973 Nov; 23(11):Suppl:1668-75. PubMed ID: 4205544
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of chronic and acute treatment with sulfonylureas on plasma insulin and glucose levels in the rat.
    Codina J; Lasuncion MA; Herrera E
    Diabete Metab; 1978 Mar; 4(1):47-52. PubMed ID: 97105
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide)].
    Loubatières A; Ribes G; Mariani MM; Alric R
    Acta Diabetol Lat; 1973; 10(2):261-82. PubMed ID: 4200420
    [No Abstract]   [Full Text] [Related]  

  • 12. Dynamics of sulfonylurea-induced insulin release from the isolated perfused rat pancreas.
    Gotfredsen CF
    Diabetologia; 1976 Aug; 12(4):339-42. PubMed ID: 134920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Kinetic aspects of the glipizide-induced hypoglycemia in the dog (author's transl)].
    Blayac JP; Ribes G; Valette JF; Loubatières-Mariani MM
    J Pharmacol; 1980; 11(4):463-72. PubMed ID: 7206734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Extrapancreatic effects of sulfonylurea compounds. IV. Increase of the effect of insulin due to tolbutamide, glibornuride, and glibenclamide in vitro].
    Beyer J; Gather W; Schöffling K
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2179. PubMed ID: 4198966
    [No Abstract]   [Full Text] [Related]  

  • 15. [Glibornuride, a new high-effective antidiabetic agent. Pharmacological and biochemical comparative studies in various animal species and animal experimental models].
    Lorch E; Gey KF; Sommer P
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2154. PubMed ID: 4198964
    [No Abstract]   [Full Text] [Related]  

  • 16. [Changes in insulin (IRI) and NEFA levels in diabetic subjects after acute intravenous glipizide and tolbutamide administration].
    Fedeli S; Maglia A
    Arch Sci Med (Torino); 1977; 134(1):33-8. PubMed ID: 860916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diurnal pattern of plasma insulin and blood glucose during glibenclamide and glipizide therapy in elderly diabetics.
    Groop L; Harno K
    Acta Endocrinol Suppl (Copenh); 1980; 239():44-52. PubMed ID: 6776763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potentiating effect of the simultaneous administration of tolbutamide, glibenclamide, and gliclazide on the development of alloxan-induced diabetes in rats.
    Katsumata K; Katsumata Y
    Horm Metab Res; 1990 Jan; 22(1):51-2. PubMed ID: 2106472
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of glipizide on muscle metabolism in vitro.
    Bloch K; Daturi S; Tommasini R
    Acta Endocrinol Suppl (Copenh); 1980; 239():23-5. PubMed ID: 7001841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Extrapancreatic effects of sulfonylurea compounds. 3. Studies on the additional blood sugar decreasing and antilipolytic effect of tolbutamide, glibornuride, and glibenclamide on completely pancreatectomized dogs, chronically treated with insulin during acute experiment and following pretreatment with sulfonylurea compounds using small doses of sulfonylurea].
    Beyer J; Cordes U; Sell G; Schöffling K
    Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2176. PubMed ID: 4198965
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.